Hill Avenue Cannabis Technologies
In a groundbreaking transaction, Hill Avenue Cannabis Co., via its parent company, acquired global usage rights to cutting-edge DehydraTECH™ Intellectual Property for incorporation into adult use CBD and THC products including edibles, infused beverages, topicals, tinctures, sublingual products, and concentrates. These usage rights were acquired from the Lexaria group of companies in 2020.
Fast-acting patented DehydraTECH™ technology improves the way active pharmaceutical ingredients (APIs) enter the bloodstream, delivering a host of competitive advantages, providing better, more predictable cannabis experiences for consumers. Findings from extensive scientific studies performed by Lexaria include:
Increased bioavailability up to 5-10x to equate to blood absorption by inhalational delivery
Increased brain permeation up to 19x as demonstrated in animal studies
Avoids first-pass liver metabolism mitigating unwanted side effects
Reduced time of onset – effects are felt within 12-20 min vs. 60-120 min
Masks unwanted tastes eliminating the need for sugar-filled edibles